Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38

Patent 11352442 was granted and assigned to Xencor on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113524420

Patent Inventor Names

Matthew J. Bernett0

Umesh Muchhal0

Seung Y. Chu0

Gregory Moore0

John Desjarlais0

Rumana Rashid0

Date of Patent

June 7, 2022

Patent Application Number

166604150

Date Filed

October 22, 2019

Patent Citations

‌

US Patent 10227410 Heterodimeric antibodies that bind CD3 and PSMA

‌

US Patent 10428155 Trispecific antibodies

‌

US Patent 10526417 Heterodimeric antibodies that bind CD3 and CD38

Patent Citations Received

‌

US Patent 11919958 Anti-CD28 compositions

Patent Primary Examiner

CPC Code

The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API